![]() |
Name |
3,5-Ditert-butyl-4-hydroxycyclohexa-2,4-dien-1-one
|
Molecular Formula | C14H22O2 | |
IUPAC Name* |
3,5-ditert-butyl-4-hydroxycyclohexa-2,4-dien-1-one
|
|
SMILES |
CC(C)(C)C1=C(C(=CC(=O)C1)C(C)(C)C)O
|
|
InChI |
InChI=1S/C14H22O2/c1-13(2,3)10-7-9(15)8-11(12(10)16)14(4,5)6/h7,16H,8H2,1-6H3
|
|
InChIKey |
VMIBWUBKVGANRX-UHFFFAOYSA-N
|
|
Synonyms |
54965-43-4; 4-Hydroxy-3,5-di-tert-butyl-2,4-cyclohexadien-1-one; 3,5-ditert-butyl-4-hydroxycyclohexa-2,4-dien-1-one; DTXSID40346156; 2,4-Cyclohexadien-1-one, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-; 3,5-Ditert-butyl-4-hydroxy-2,4-cyclohexadien-1-one #
|
|
CAS | 54965-43-4 | |
PubChem CID | 610030 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 222.32 | ALogp: | 2.8 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 37.3 | Aromatic Rings: | 1 |
Heavy Atoms: | 16 | QED Weighted: | 0.656 |
Caco-2 Permeability: | -5.004 | MDCK Permeability: | 0.00001280 |
Pgp-inhibitor: | 0.606 | Pgp-substrate: | 0.009 |
Human Intestinal Absorption (HIA): | 0.696 | 20% Bioavailability (F20%): | 0.998 |
30% Bioavailability (F30%): | 0.993 |
Blood-Brain-Barrier Penetration (BBB): | 0.334 | Plasma Protein Binding (PPB): | 97.41% |
Volume Distribution (VD): | 4.385 | Fu: | 5.44% |
CYP1A2-inhibitor: | 0.896 | CYP1A2-substrate: | 0.913 |
CYP2C19-inhibitor: | 0.479 | CYP2C19-substrate: | 0.53 |
CYP2C9-inhibitor: | 0.494 | CYP2C9-substrate: | 0.916 |
CYP2D6-inhibitor: | 0.874 | CYP2D6-substrate: | 0.884 |
CYP3A4-inhibitor: | 0.341 | CYP3A4-substrate: | 0.449 |
Clearance (CL): | 8.294 | Half-life (T1/2): | 0.766 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.045 |
Drug-inuced Liver Injury (DILI): | 0.018 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.13 | Maximum Recommended Daily Dose: | 0.845 |
Skin Sensitization: | 0.919 | Carcinogencity: | 0.031 |
Eye Corrosion: | 0.904 | Eye Irritation: | 0.954 |
Respiratory Toxicity: | 0.751 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000452 | ![]() |
0.481 | D0W7WC | ![]() |
0.269 | ||
ENC000730 | ![]() |
0.481 | D09EBS | ![]() |
0.247 | ||
ENC000513 | ![]() |
0.481 | D01JFT | ![]() |
0.235 | ||
ENC000811 | ![]() |
0.456 | D00NJL | ![]() |
0.224 | ||
ENC000708 | ![]() |
0.407 | D0Y4DY | ![]() |
0.219 | ||
ENC000725 | ![]() |
0.404 | D0H2DQ | ![]() |
0.217 | ||
ENC000346 | ![]() |
0.404 | D06YPU | ![]() |
0.215 | ||
ENC000079 | ![]() |
0.404 | D03GCJ | ![]() |
0.195 | ||
ENC000610 | ![]() |
0.404 | D00IUG | ![]() |
0.195 | ||
ENC001233 | ![]() |
0.394 | D0M8RC | ![]() |
0.188 |